Animal models for SLE

Current Protocols in Immunology
Philip L Cohen, Michael A Maldonado

Abstract

Systemic lupus erythematosus (SLE) in humans is characterized by inflammatory lesions in skin, joints, kidneys, the central nervous system (CNS), and elsewhere. The clinical manifestations are accompanied by autoantibodies to diverse self antigens, mainly but not exclusively derived from the cell nucleus. Autoantibodies are generally believed to cause most of the tissue damage, although direct injury via cell-mediated immunity is also important. This unit describes protocols for the quantitation of SLE-associated autoantibody levels in mouse serum: detection of anti-chromatin antibodies, detection of anti-single and anti-double-stranded DNA antibodies, and detection of rheumatoid factor. Support protocols for preparing chicken chromatin and dsDNA are included. Also included is an immunoglobulin allotype-specific adaptation of the basic autoantibody ELISA which is useful for measuring antibody production in chimeric animals. The unit includes an ELISPOT protocol for quantitating cells producing anti-chromatin, as well as a method for genotyping mice for the faslpr and fasLgld mutations.

Citations

Mar 23, 2011·The Journal of Experimental Medicine·Marton KeszeiCox Terhorst
Sep 22, 2011·Current Protocols in Pharmacology·Matthew M SeaveyKristine L Stump
Nov 15, 2017·Cardiovascular Endocrinology·Omid Sadeghi-AlavijehBen Caplin
Apr 26, 2011·The American Journal of Pathology·Jung-hyun RhoJulia Y Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.